Legal & General Group Plc Acquires New Shares in HealthEquity, Inc. $HQY

Key Points

• Legal & General Group acquired 118,522 HealthEquity shares worth approximately $10.7 million, representing about 0.14% of the company. Institutional investors collectively own 99.55% of HealthEquity.
• HealthEquity beat quarterly expectations with $1.24 EPS versus the $1.19 consensus and revenue of $350.73 million, up 95.5% year over year. Management issued fiscal 2027 EPS guidance of $4.66–$4.73.
• Analysts maintain a “Moderate Buy” consensus, with an average price target of $111.87 compared with the stock’s reported $96.54 price. Insiders sold 12,456 shares worth about $1.26 million over the past 90 days.

Legal & General Group Plc bought a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 118,522 shares of the company's stock, valued at approximately $10,705,000. Legal & General Group Plc owned about 0.14% of HealthEquity at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. BlackRock Inc. bought a new position in shares of HealthEquity during the second quarter valued at $1,018,621,000. Wasatch Advisors LP increased its holdings in HealthEquity by 10.5% in the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company's stock worth $719,014,000 after buying an additional 757,801 shares in the last quarter. Geode Capital Management LLC raised its position in HealthEquity by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company's stock worth $201,685,000 after buying an additional 5,671 shares during the last quarter. Westfield Capital Management Co. LP raised its position in HealthEquity by 13.7% in the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company's stock worth $178,864,000 after buying an additional 235,794 shares during the last quarter. Finally, William Blair Investment Management LLC bought a new position in HealthEquity during the 4th quarter valued at about $169,956,000. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $96.54 on Tuesday. The stock has a market cap of $7.98 billion, a PE ratio of 34.85, a price-to-earnings-growth ratio of 1.53 and a beta of 0.21. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62. The firm has a fifty day moving average price of $98.40 and a 200-day moving average price of $88.06. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.05. The company had revenue of $350.73 million for the quarter, compared to analysts' expectations of $349.22 million. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company's revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Adrian T. Dillon sold 7,632 shares of the business's stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director directly owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,470 shares of the company's stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the completion of the transaction, the executive vice president directly owned 56,643 shares of the company's stock, valued at approximately $5,381,085. This trade represents a 4.18% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,456 shares of company stock worth $1,256,664 over the last 90 days. Company insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on HQY. Citizens Jmp lifted their price target on shares of HealthEquity from $110.00 to $111.00 and gave the stock a "market outperform" rating in a research note on Monday, June 1st. Wells Fargo & Company set a $111.00 price objective on shares of HealthEquity in a research report on Monday, June 1st. Royal Bank Of Canada raised their target price on shares of HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a report on Wednesday, June 3rd. Barrington Research reaffirmed an "outperform" rating and issued a $110.00 target price on shares of HealthEquity in a research report on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a research note on Monday. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $111.87.

About HealthEquity

HealthEquity, Inc NASDAQ: HQY is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source